ENTREP2 Gene

Name endosomal transmembrane epsin interactor 2
Description Predicted to be located in membrane. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPlexin receptors are best recognized for their roles in cell adhesion, migration, and the guidance of developing axons. In the nervous system, Plexin C1 (PLXNC1) serves as a key mediator of semaphorin‐induced signals that shape neuronal migration and synapse formation. For example, in the hypothalamus, proper PLXNC1 expression is required for the normal positioning of vasopressin and oxytocin neurons, and its altered regulation is associated with neuronal mis‐placement ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]. In the olfactory pathway, activity‐dependent cues—most notably Sema7A—engage PLXNC1 expressed on mitral/tufted cell dendrites during a neonatal critical period, promoting post‐synaptic assembly and dendrite selection that influence odor imprinting and connectivity ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "]. Furthermore, studies comparing plexin subfamilies have shown that, similar to Plexin‐D1 and Plexin‐C1, this receptor can modulate R‐Ras activity—a mechanism likely contributing to repulsive guidance signals in developing neurons ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOutside the nervous system, PLXNC1 has emerged as an important regulator of immune cell behavior and inflammatory responses. In models of acute inflammation, PLXNC1 is expressed by leukocytes where it affects the rolling, adhesion, and transendothelial migration necessary for an effective inflammatory response; indeed, both antibody‐mediated blockade and genetic deletion of PLXNC1 markedly reduce these responses in peritonitis ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "]. In the context of pulmonary fibrosis, deficiency of PLXNC1 leads to excessive macrophage migration mediated by synaptotagmin 7 (Syt7), which in turn exacerbates collagen accumulation and fibrotic changes in the lung, an effect reversible by restoring PLXNC1 expression in hematopoietic cells ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "]. Recent findings further suggest that PLXNC1 influences intracellular lipopolysaccharide (LPS) sensing and downstream caspase‐11 activation, linking axon guidance molecules to innate immune mechanisms ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPLXNC1 also plays nuanced roles in regulating cell migration and growth in non‐neuronal tissues, with implications for both normal physiology and disease. In melanocytes and primary melanoma cells, PLXNC1 functions as a tumor suppressor by lowering R‐Ras activity, thereby reducing migratory and proliferative capacities; loss of PLXNC1 in melanocytes is associated with increased cell migration that may predispose to early melanoma progression ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "]. Moreover, in the formation of dopaminergic circuits, PLXNC1 expression is tightly coordinated by transcription factors (such as Otx2 and Lmx1a/b) to ensure proper segregation of nigrostriatal and mesolimbic pathways, emphasizing its role in the fine‐tuning of neuronal connectivity and behavior ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "]. In a related yet distinct vein, studies of RasL11a—a chromatin‐associated modulator of ribosomal RNA synthesis—highlight broader intracellular signaling networks that intersect with those regulated by plexin receptors, offering insights into how diverse intracellular cues might integrate with PLXNC1‐mediated processes ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "].\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Cheng Xu, Chen-Ming Fan "}, {"type": "b", "children": [{"type": "t", "text": "Allocation of paraventricular and supraoptic neurons requires Sim1 function: a role for a Sim1 downstream gene PlexinC1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0034"}], "href": "https://doi.org/10.1210/me.2007-0034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17356169"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17356169"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Nobuko Inoue, Hirofumi Nishizumi, Hiromi Naritsuka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sema7A/PlxnCl signaling triggers activity-dependent olfactory synapse formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-04239-z"}], "href": "https://doi.org/10.1038/s41467-018-04239-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29743476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29743476"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Nobuko Inoue, Hirofumi Nishizumi, Rumi Ooyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The olfactory critical period is determined by activity-dependent Sema7A/PlxnC1 signaling within glomeruli."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.65078"}], "href": "https://doi.org/10.7554/eLife.65078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33780330"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33780330"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kanami Uesugi, Izumi Oinuma, Hironori Katoh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Different requirement for Rnd GTPases of R-Ras GAP activity of Plexin-C1 and Plexin-D1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M805213200"}], "href": "https://doi.org/10.1074/jbc.M805213200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19136556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19136556"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Klemens König, Linda Marth, Jan Roissant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The plexin C1 receptor promotes acute inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.201343968"}], "href": "https://doi.org/10.1002/eji.201343968"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24890788"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24890788"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xueyan Peng, Meagan Moore, Aditi Mathur, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201600373R"}], "href": "https://doi.org/10.1096/fj.201600373R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27609773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27609773"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Alice Bernard, Claudia Eggstein, Linyan Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plexin C1 influences immune response to intracellular LPS and survival in murine sepsis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biomed Sci (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12929-024-01074-x"}], "href": "https://doi.org/10.1186/s12929-024-01074-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39169397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39169397"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Y Chen, J Soong, S Mohanty, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The neural guidance receptor Plexin C1 delays melanoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.511"}], "href": "https://doi.org/10.1038/onc.2012.511"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23160370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23160370"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Audrey Chabrat, Guillaume Brisson, Hélène Doucet-Beaupré, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional repression of Plxnc1 by Lmx1a and Lmx1b directs topographic dopaminergic circuit formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-017-01042-0"}], "href": "https://doi.org/10.1038/s41467-017-01042-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29038581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29038581"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Mariaelena Pistoni, Alessandro Verrecchia, Mirko Doni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromatin association and regulation of rDNA transcription by the Ras-family protein RasL11a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emboj.2010.16"}], "href": "https://doi.org/10.1038/emboj.2010.16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20168301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20168301"}]}]}]}
NCBI Gene ID 23359
API
Download Associations
Predicted Functions View ENTREP2's ARCHS4 Predicted Functions.
Co-expressed Genes View ENTREP2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View ENTREP2's ARCHS4 Predicted Functions.

Functional Associations

ENTREP2 has 1,406 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 23 datasets.

Click the + buttons to view associations for ENTREP2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ENTREP2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of ENTREP2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CellMarker Gene-Cell Type Associations cell types associated with ENTREP2 gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of ENTREP2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing ENTREP2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with ENTREP2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of ENTREP2 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of ENTREP2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of ENTREP2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with ENTREP2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with ENTREP2 gene from the HuBMAP Azimuth Cell Type Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of ENTREP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of ENTREP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of ENTREP2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of ENTREP2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of ENTREP2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of ENTREP2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of ENTREP2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of ENTREP2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of ENTREP2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of ENTREP2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with ENTREP2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving ENTREP2 protein from the WikiPathways Pathways 2024 dataset.